| Financial Year |
March 31 2023 |
| Monetary Funds |
341,038,476.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
206,204,201.09 |
| Accounts Receivable |
614,356,310.71 |
| Advances to Suppliers |
95,198,878.30 |
| Other Receivables |
35,191,594.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
647,474,337.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,181,061.43 |
| Total Current Assets |
1,983,421,908.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
344,041,296.90 |
| Investment Properties |
92,826,090.81 |
| Fixed Assetes |
1,829,275,149.72 |
| Under-construction Projects |
175,386,994.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
329,148,916.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,809.27 |
| Deferred Income Tax Assets |
13,482,962.60 |
| Other Non-Current Assets |
9,802,424.73 |
| Sub-Total of Non-Current Assets |
2,793,979,645.23 |
| Total Assets |
4,777,401,553.54 |
| Short-Term Loans |
350,254,680.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,231,224.97 |
| Accounts Payable |
433,971,821.67 |
| Accounts Received In Advance |
121,728.50 |
| Employee Compensation Payable |
40,396,846.62 |
| Taxes Payable |
43,872,809.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,078,109.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
189,389.24 |
| Sub-Total of Current Liabilities |
988,869,440.07 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,057,465.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,991,006.90 |
| Total Liabilities |
1,011,860,446.97 |
| Paid-In Capital(Or Share Stock) |
1,500,000,000.00 |
| Capital Surplus |
1,684,481,587.69 |
| Surplus Reserve |
394,236,241.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
186,823,277.52 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,765,541,106.57 |
| Owner's Equity（Stockholder's Equity） |
3,765,541,106.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,777,401,553.54 |
